Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).

Schweitzer VG, Rarey KE, Dolan DF, Abrams G, Litterst CJ, Sheridan C.

Otolaryngol Head Neck Surg. 1986 Apr;94(4):458-70.

PMID:
3086808
2.

Vestibular morphological analysis of the effects of cisplatin vs. platinum analogs, CBDCA (JM-8) and CHIP (JM-9).

Schweitzer VG, Rarey KE, Dolan DF, Abrams GE, Sheridan C.

Laryngoscope. 1986 Sep;96(9 Pt 1):959-74.

PMID:
3528727
3.

Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents.

Schweitzer VG.

Laryngoscope. 1993 Apr;103(4 Pt 2):1-52. Review.

PMID:
8464301
4.

Amelioration of cisplatin-induced ototoxicity by fosfomycin.

Schweitzer VG, Dolan DF, Abrams GE, Davidson T, Snyder R.

Laryngoscope. 1986 Sep;96(9 Pt 1):948-58.

PMID:
3747696
5.

Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis.

Kohn S, Fradis M, Pratt H, Zidan J, Podoshin L, Robinson E, Nir I.

Laryngoscope. 1988 Aug;98(8 Pt 1):865-71.

PMID:
3398664
6.

Preclinical toxicology of platinum analogues in dogs.

Lelieveld P, van der Vijgh WJ, van Velzen D.

Eur J Cancer Clin Oncol. 1987 Aug;23(8):1147-54.

PMID:
3308482
7.

Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.

Smith JH, Smith MA, Litterst CL, Copley MP, Uozumi J, Boyd MR.

Fundam Appl Toxicol. 1988 Jan;10(1):45-61.

PMID:
3350229
8.

Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.

Schweitzer VG, Hawkins JE, Lilly DJ, Litterst CJ, Abrams G, Davis JA, Christy M.

Otolaryngol Head Neck Surg. 1984 Feb;92(1):38-49.

PMID:
6422414
9.

In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.

Smith MA, Smith JH, Litterst CL, Copley MP, Uozumi J, Boyd MR.

Fundam Appl Toxicol. 1988 Jan;10(1):62-72.

PMID:
3350230
10.

Ototoxicity of the new platinum anticancer agent TRK-710 in comparison with cisplatin.

Saito T, Manabe Y, Saito H.

ORL J Otorhinolaryngol Relat Spec. 1995 Sep-Oct;57(5):250-5.

PMID:
8587776
11.

Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.

Prajda N, Kralovánszky J, Gal F, Kiss F, Kerpel-Fronius S.

In Vivo. 1989 Jul-Aug;3(4):267-70.

PMID:
2519864
12.

Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP).

Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Kiss F.

Cancer Chemother Pharmacol. 1988;21(1):40-4.

PMID:
3277733
13.

High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.

Thomas JP, Lautermann J, Liedert B, Seiler F, Thomale J.

Mol Pharmacol. 2006 Jul;70(1):23-9. Epub 2006 Mar 28.

14.

Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.

Sun C, Wang X, Chen D, Lin X, Yu D, Wu H.

Neurosci Lett. 2016 Apr 21;619:142-8. doi: 10.1016/j.neulet.2016.03.012. Epub 2016 Mar 10.

PMID:
26971701
15.

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.

Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.

Cancer Res. 1984 Apr;44(4):1693-7.

16.

Carboplatin ototoxicity in the chinchilla: lesions of the vestibular sensory epithelium.

Mount RJ, Takeno S, Wake M, Harrison RV.

Acta Otolaryngol Suppl. 1995;519:60-5.

PMID:
7610893
17.

Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs.

Teranishi M, Nakashima T, Wakabayashi T.

Hear Res. 2001 Jan;151(1-2):61-70.

PMID:
11124452
18.

Ototoxicity of carboplatin in guinea pigs.

Saito T, Saito H, Saito K, Wakui S, Manabe Y, Tsuda G.

Auris Nasus Larynx. 1989;16(1):13-21.

PMID:
2475098
19.

Preclinical studies identifying carboplatin as a viable cisplatin alternative.

Harrap KR.

Cancer Treat Rev. 1985 Sep;12 Suppl A:21-33.

PMID:
3910219
20.

Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.

Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG.

Am J Otolaryngol. 2009 Jan-Feb;30(1):1-7. doi: 10.1016/j.amjoto.2007.12.003. Epub 2008 Jun 20.

PMID:
19027506

Supplemental Content

Support Center